De Novo Peptide Sequencing
De novo peptide sequencing enables researchers to determine the amino acid sequences of peptides or proteins without relying on a reference sequence. This technology has significantly advanced our understanding of protein diversity and complexity, particularly in the analysis of unknown, variant, or non-model organism proteins, demonstrating its distinct advantages.
De novo peptide sequencing integrates mass spectrometry with computational algorithms. The technique utilizes mass spectrometry for high-precision analysis of peptide fragments, employing methods such as high-energy collision dissociation (HCD), collision-induced dissociation (CID), and electron transfer dissociation (ETD) to generate characteristic fragment ions. The mass-to-charge ratios (m/z values) of these ions contain structural information about the amino acid residues. Computational algorithms then interpret these data to reconstruct the peptide sequences. Commonly used approaches include spectrum matching algorithms, probabilistic models, and neural network-based methods.
Analysis Workflow
The workflow of de novo peptide sequencing involves the following steps:
1. Sample Preparation
Peptide samples are purified and desalted to ensure complete peptide release and reduce background interference, enhancing the sensitivity of mass spectrometry analysis.
2. Mass Spectrometry Analysis
Peptide mixtures are analyzed using high-resolution mass spectrometers, such as quadrupole time-of-flight (Q-TOF), linear ion trap (LTQ), and Orbitrap instruments. The resulting mass spectra include peaks representing fragment ions with different m/z values.
3. Data Analysis
Specialized software processes the mass spectrometry data to reconstruct peptide sequences, considering factors such as fragment ion intensity, m/z accuracy, and amino acid physicochemical properties.
Applications
De novo peptide sequencing finds extensive applications across various fields:
1. Peptidomics
Facilitates the identification of novel peptides without reference sequences, enriching omics databases.
2. Disease Biomarkers
Unveils novel peptide biomarkers linked to specific diseases, providing insights for early diagnosis and treatment.
3. Microbiology
Reveals unique peptide compositions of non-model organisms or environmental microbes, aiding in the study of ecological functions and evolutionary relationships.
4. Drug Development
Identifies target proteins for drug design, improving drug optimization and screening strategies.
As a pivotal tool in proteomics, de novo peptide sequencing has proven its significant applicability across diverse scientific domains.
MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.
Related Services
How to order?
